Skip to main content

Table 1 The Basic Characteristics of MDR/XDR Acinetobacter baumannii patients

From: Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit

Characteristics

n (%)

 

Survivors

72 (70.59)

Nonsurvivors

30 (29.41)

Odds Ratio

(95%CI)

P value

Age, mean ± SD, month

 

30 (9.6, 88.75)

42 (9.825, 102.75)

0.691 (−29.63, 12.02)

0.404

Male/Female (n=)

 

44/28

19/11

(0.286,0.478)

0.835

Underlying disorders

Pneumonia n (%)

61 (84.7)

25 (83.3)

0.902 (0.284,2.862)

0.862

Meningitis n (%)

1 (1.38)

6 (20)

17.75 (2.033,154.993)

< 0.001*

Leukemia/Solid tumor n (%)

6 (8.33)/10 (13.89)

6 (20)/11 (33.3)

4.577 (1.84, 51.383)

< 0.001

Trauma n (%)

3 (4.17)

0 (0)

0.557 (0.547, 0.567)

0.553

Sepsis n (%)

65 (90.27)

25 (83.33)

0.538 (0.156, 1.855)

0.321

Peritonitis n (%)

8 (11.11)

8 (26.67)

2.909 (0.975, 8.68)

0.049

Cardiovascular disease n (%)

8 (11.11)

5 (16.67)

1.35 (0.401, 0.454)

0.627

Hepatic disorder n (%)

5 (6.94)

2 (6.67)

0.814 (0.149, 4.462)

0.813

Others n (%)

10 (13.89)

5 (16.67)

1.24 (0.385, 3.994)

0.718

WBC count(*109/L)

M(Q1,Q3)

7.99 (5.81, 13.62)

5.1 (1.64, 14.78)

 

0.046

Neutropenia(*109/L)

M(Q1,Q3)

4.88 (3.51, 9.1)

3.37 (0.61, 11.05)

 

0.158

CRP (mg/L)

M(Q1,Q3)

37 (10, 74)

27 (16, 94.5)

 

0.406

PCT (ng/L)

M(Q1,Q3)

0.48 (0.18, 5.08)

1.56 (0.53, 8.27)

 

0.066

Lactate (mmol/L)

 mean ± SD

3.12 ± 2.9

3.09 ± 2.42

 

0.955

PRISM III

 mean ± SD

6.73 ± 5.19

8.3 ± 4.76

 

0.183

Shock

 n (%)

18, 25%

16, 53.33%

3.429 (1.403, 8.382)

0.006*

PaO2/FiO2

 mean ± SD

269 ± 113.55

220.96 ± 150.16

 

0.139

Exposure factors

     

Steroid n (%)

49 (68.06)

21 (70)

1.619 (0.662, 3.963)

0.289

Immune suppressor n (%)

11 (15.27)

8 (26.67)

2.017 (0.718, 5.665)

0.263

Length of hospital day (day,M(Q1,Q3))

24 (14, 48.75)

31.5 (24.75, 41.5)

 

0.605

Length of PICU day (day,M(Q1,Q3))

14 (8,23.5)

22.5 (13.25, 41)

 

0.459

Length of broad-spectrum antibiotic therapy (day,M(Q1,Q3))

22 (12, 43)

31.5 (24.75, 41.5)

 

0.123

Length of mechanical ventilation (day, M(Q1,Q3))

6 (1, 15)

10 (6, 25)

 

0.02

Length of CRRT/ECMO(h, M(Q1,Q3))

0 (0, 0)

0 (0, 6)

 

0.02

Central vein catheter n (%)

69 (95.83)

30 (100)

1.435 (1.26, 1.634)

0.256

Arterial catheter

n (%)

58 (80.56)

29 (96.67)

7.0 (0.877, 55.872)

0.036

Intra trachea intubation n (%)

57 (79.17)

29 (96.67)

7.632 (0.96, 60.662)

0.027

Operation n (%)

31 (43.06)

20 (66.67)

2.645 (1.085, 6.448)

0.03

  1. *p < 0.01